HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nikhil Hebbar Selected Research

Arylquin 1

11/2014Arylquins target vimentin to trigger Par-4 secretion for tumor cell apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nikhil Hebbar Research Topics

Disease

10Neoplasms (Cancer)
01/2022 - 12/2012
2Breast Neoplasms (Breast Cancer)
07/2013 - 01/2013
1Obesity
01/2022
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022
1Neoplasm Metastasis (Metastasis)
10/2017

Drug/Important Bio-Agent (IBA)

4Endoplasmic Reticulum Chaperone BiPIBA
01/2022 - 12/2012
3Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
10/2017 - 12/2012
2Proteins (Proteins, Gene)FDA Link
12/2019 - 01/2017
1Complement System Proteins (Complement)IBA
01/2022
1Biological ProductsIBA
12/2019
1Pharmaceutical PreparationsIBA
10/2017
1Chloroquine (Aralen)FDA LinkGeneric
10/2017
1Antimalarials (Antimalarial Agents)IBA
10/2017
1UbiquitinIBA
01/2017
1prostate apoptosis response-4 proteinIBA
01/2017
1Ligases (Synthetase)IBA
01/2017
1CaspasesIBA
01/2017
1Arylquin 1IBA
11/2014
1SecretagoguesIBA
11/2014
1VimentinIBA
11/2014
1Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
12/2012

Therapy/Procedure

4Therapeutics
01/2017 - 01/2013
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
12/2012